Beyond therapeutics, monoclonal antibodies shown to be effective in the clinic can help to facilitate laboratory research. Researchers use mAbs, also known as biosimilars, as tools to research novel therapies and uncover effective off-target applications. With known and approved data on toxicity and efficacy, researchers use these biologics as benchmarks in their studies, allowing them to accelerate their findings from bench to clinic.
ProSci offers more than 800 research-grade biosimilar antibodies in the following research areas: cancer, pain, blood-related diseases, bacterial infection, neurodegenerative, asthma, psoriasis and other dermatitis, rheumatoid arthritis and osteoporosis, inflammatory diseases, Crohn’s disease, virus infection, and diabetes and other autoimmune diseases.
Phone: 02 9698 2022
Bio-Rad Laboratories StarBright Red 715, 775 and 815 Dyes and expanded antibody markers
The StarBright Dyes — proprietary fluorescent nanoparticles conjugated to flow-validated...
RevMAb Biosciences histone family protein monoclonal antibodies
RevMAb Biosciences offers a wide range of recombinant monoclonal antibodies against histone...
Biosensis MAP2 antibodies
Biosensis's validated MAP2 antibodies are designed to help users identify MAP2, whether they...